Clinical trial · Interventional
Evaluation of The Radioprotective Effect of 3D-Printed Intraoral Stents in Children With Brain Cancer.
Evaluation of The Radioprotective Effect of 3D-Printed Intraoral Stents in Children With Brain Cancer: A Randomized Clinical Trial and An In-Vitro Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Brain cancer patients undergoing radiotherapy may experience oral complications such as oral mucositis, gingival inflammation, plaque accumulation, radiation-induced caries, and reduced oral-health-related quality of life due to scatter radiation affecting oral tissues. Although intraoral stents are used to protect and reposition oral structures during radiotherapy, conventional stents lack standardization in material properties and thickness, leading to variable radioprotective effectiveness. Advances in 3D printing allow fabrication of customized resin intraoral stents with controlled thickness. However, there is not a lot of research in the literature about the materials that are employed as intraoral radiation stents to reduce the radiation dosage received by healthy tissue. Since these devices can lower radiation exposure to healthy tissues, the current study seeks to evaluate the degree of attenuation of therapeutic radiation with four different thicknesses for the intraoral stents and then assess the clinical effectiveness of the optimized thickness of the 3D-printed resin intraoral stent in reducing oral mucositis, periodontal health status, radiation induced caries, and in improving patient-reported outcomes in brain cancer patients undergoing radiotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Medulloblastoma Tumor | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 3D printed intraoral stents. | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 3D printed intraoral stent group
- description
- Patients will wear the 3D printed intraoral stent during radiotherapy sessions.
- interventionNames
- Device: 3D printed intraoral stents.
- type
- NO_INTERVENTION
- label
- Standard care control group
- description
- Patients receiving standard oral care instructions without the use of an intraoral stent (control group).
Primary outcomes (1)
- measure
- Assessment of the oral mucositis severity in children below 18 years old diagnosed with medulloblastoma tumor.
- timeFrame
- Assessments will be carried out weekly during radiotherapy and 3 months after radiotherapy.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients who will receive 5-7 weeks of definitive radiotherapy for treatment of a diagnosed medulloblastoma tumor. 2. Age less than 18 years old. 3. No Evidence of oral mucositis at baseline (WHO grade 0) Exclusion Criteria: 1. Patients with prior exposure to head and neck radiotherapy. 2. Patients who are unable to wear oral stent. 3. Patients with known allergies or hypersensitivity to dental resin materials.
References
Publications (2)
- BACKGROUNDAggarwal H, Kumar P. Radiation stents: Minimizing radiation-induced complications. South Asian J Cancer. 2014 Jul;3(3):185. doi: 10.4103/2278-330X.136812. No abstract available. PMID 25136529
- BACKGROUNDTanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB. Oral and dental late effects in long-term survivors of childhood embryonal brain tumors. Support Care Cancer. 2022 Dec;30(12):10233-10241. doi: 10.1007/s00520-022-07405-8. Epub 2022 Oct 29. PMID 36307656